These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 27362406

  • 1. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T, Johnston S, Chacko A, Gibson D, Cepon J, Smith P, Staines D, Marshall-Gradisnik S.
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [Abstract] [Full Text] [Related]

  • 2. Investigation of mast cell toll-like receptor 3 in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Systemic Mastocytosis using the novel application of autoMACS magnetic separation and flow cytometry.
    Balinas C, Nguyen T, Johnston S, Smith P, Staines D, Marshall-Gradisnik S.
    Asian Pac J Allergy Immunol; 2018 Dec; 36(4):257-264. PubMed ID: 29223146
    [Abstract] [Full Text] [Related]

  • 3. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
    Nguyen T, Staines D, Nilius B, Smith P, Marshall-Gradisnik S.
    Biol Res; 2016 May 31; 49(1):27. PubMed ID: 27245705
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M, Bosmans E, Kubera M.
    Neuro Endocrinol Lett; 2015 May 31; 36(5):439-46. PubMed ID: 26707044
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, Ramos S, Staines D, Marshall-Gradisnik S.
    BMC Immunol; 2015 Jun 02; 16():35. PubMed ID: 26032326
    [Abstract] [Full Text] [Related]

  • 6. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Rivas JL, Palencia T, Fernández G, García M.
    Front Immunol; 2018 Jun 02; 9():1028. PubMed ID: 29867995
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.
    J Transl Med; 2015 Sep 14; 13():299. PubMed ID: 26370228
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, Tajouri L, Peterson D, Ramos SB, Marshall-Gradisnik SM.
    J Transl Med; 2012 May 09; 10():88. PubMed ID: 22571715
    [Abstract] [Full Text] [Related]

  • 9. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E, Carrillo J, Urrea V, Rigau J, Alegre J, Cabrera C, Oltra E, Castro-Marrero J, Blanco J.
    Front Immunol; 2020 May 09; 11():582330. PubMed ID: 33329554
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M, Twisk FN, Ringel K.
    Psychother Psychosom; 2012 May 09; 81(5):286-95. PubMed ID: 22832503
    [Abstract] [Full Text] [Related]

  • 11. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
    Mensah F, Bansal A, Berkovitz S, Sharma A, Reddy V, Leandro MJ, Cambridge G.
    Clin Exp Immunol; 2016 May 09; 184(2):237-47. PubMed ID: 26646713
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
    Ramos S, Brenu E, Broadley S, Kwiatek R, Ng J, Nguyen T, Freeman S, Staines D, Marshall-Gradisnik S.
    Asian Pac J Allergy Immunol; 2016 Dec 09; 34(4):300-305. PubMed ID: 27001659
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM.
    J Transl Med; 2011 May 28; 9():81. PubMed ID: 21619669
    [Abstract] [Full Text] [Related]

  • 16. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).
    Corbitt M, Eaton-Fitch N, Staines D, Cabanas H, Marshall-Gradisnik S.
    BMC Neurol; 2019 Aug 24; 19(1):207. PubMed ID: 31445522
    [Abstract] [Full Text] [Related]

  • 17. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H, Muraki K, Eaton N, Balinas C, Staines D, Marshall-Gradisnik S.
    Mol Med; 2018 Aug 14; 24(1):44. PubMed ID: 30134818
    [Abstract] [Full Text] [Related]

  • 18. Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
    Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Ramos S, Staines D, Marshall-Gradisnik S.
    Int J Med Sci; 2015 Aug 14; 12(10):764-72. PubMed ID: 26516304
    [Abstract] [Full Text] [Related]

  • 19. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
    Jonsjö MA, Olsson GL, Wicksell RK, Alving K, Holmström L, Andreasson A.
    Psychoneuroendocrinology; 2020 Mar 14; 113():104578. PubMed ID: 31901625
    [Abstract] [Full Text] [Related]

  • 20. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H, Muraki K, Balinas C, Eaton-Fitch N, Staines D, Marshall-Gradisnik S.
    Mol Med; 2019 Apr 23; 25(1):14. PubMed ID: 31014226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.